OptiNose, Inc(NASDAQ:OPTN) 
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery sys...
Website: http://www.optinose.com
Founded: 2000
Full Time Employees: 221
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-11-19
P
O 5.70
H 5.70
L 4.95
C 5.10
V 4,909,298
10EMA 5.10
20EMA 5.10
60EMA 5.10
120EMA 5.10
250EMA 5.10